Patent · US Active

CRISPR enzymes and systems

US11091798B2 · kind B2 · utility

16Cited by
5References
27Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 27, 2018
Grant dateAug 17, 2021
Priority date
Expiry dateJul 5, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/80
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention provides for systems, methods, and compositions for targeting nucleic acids. In particular, the invention provides non-naturally occurring or engineered DNA-targeting systems comprising a novel DNA-targeting CRISPR effector protein and at least one targeting nucleic acid component like a guide RNA. Methods for making and using and uses of such systems, methods, and compositions and products from such methods and uses are also disclosed and claimed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.